產品分類
Product Category詳細介紹
| 品牌 | absin | CAS | 49562-28-9 |
|---|---|---|---|
| 分子式 | C20H21ClO4 | 純度 | 98% |
| 分子量 | 360.83 | 貨號 | abs47027522 |
| 規格 | 100mg | 供貨周期 | 現貨 |
| 主要用途 | is a Peroxisome Proliferator Receptor al | 應用領域 | 化工,生物產業,農林牧漁,制藥/生物制藥,綜合 |
Fenofibrate 49562-28-9
| 產品描述 | |
| 描述 | Fenofibrate is a Peroxisome Proliferator Receptor alpha Agonist. The mechanism of action of fenofibrate is as a Peroxisome Proliferator-activated Receptor alpha Agonist. The chemical classification of fenofibrate is PPAR alpha. |
| 純度 | 98% |
| 儲存/保存方法 | Store at -20℃ for one year(Powder);Store at 2-4℃ for two weeks;Store at -20℃ for six months after dissolution. |
| 基本信息 | |
| 別名 | fei諾貝特 |
| 外觀 | 白色或類白色結晶性粉末 |
| 可溶性/溶解性 | DMSO : 36.1 mg/mL (100 mM) Ethanol : 36.1 mg/mL (100 mM) |
| 生物活性 | |
| 靶點 | Cytochrome P450 |
| In vivo(體內研究) | Daily intake of Fenofibrate at this low dose (10 μg/g/day) inhibits retinal and choroidal neovascularization induced by CYP2C8 overexpression by 29% (P=0.021) and 36% (P=1.2×10?9) respectively. |
| 參考文獻 | |
| 參考文獻 |
|
| 研究領域 | |
| 研究領域 | CardiovascularLipids / LipoproteinsLipid MetabolismCytochromes MetabolismPathways and ProcessesMetabolic signaling pathwaysDrug metabolism MetabolismPathways and ProcessesMetabolic signaling pathwaysLipid and lipoprotein metabolismLipases MetabolismPathways and ProcessesMitochondrial MetabolismCytochromes NeuroscienceDevelopment NeuroscienceProcesses Signal TransductionMetabolismDrug metabolism Drug DiscoverySmall Molecule DrugLead Compound Discovery |
產品咨詢
電話
微信掃一掃